Randomized Controlled Trials (RCT)

A Randomized Controlled Trial (RCT) is an interventional or experimental study where subjects are randomly allocated to either a control or an intervention group.
It is universally considered the gold standard for clinical research because the randomization process minimizes the chance that confounding variables (both known and unknown) will differ between the compared groups.
By strictly controlling the intervention, RCTs allow researchers to establish a highly reliable estimate of causation between the treatment and the observed outcome.
Clinical trials must be randomized, controlled, and possess adequate statistical power to detect clinically meaningful differences.

Selection of a sample from the target population based on strictly defined inclusion and exclusion criteria.
Measuring baseline variables to ensure the comparability of the groups before the intervention begins.
Randomization of subjects into the study arms to eliminate baseline confounding.
Blinding of the intervention to eliminate ascertainment and observer bias.
Meticulous follow-up of subjects to ensure adherence to the protocol and to account for any patients lost to follow-up.
Measuring the outcome using clinically important measures and meticulously recording any adverse events.

Simple Randomization: Each patient is randomly and independently allocated to a group (similar to flipping a coin), giving each a 50/50 chance of receiving the new drug or placebo. A major weakness is that it can result in unequal sample sizes between groups, especially in smaller studies.
Block Randomization: Patients are divided into blocks (often of equal or varying sizes) and independently randomized within each block to ensure equal sample sizes and to prevent covariate imbalance over time.
Stratified Randomization: Patients are first grouped according to pre-specified prognostic covariate values (e.g., age, gender, disease severity) to form strata, and then separate block randomization is carried out within each stratum.

The comparison in an RCT is typically done against either an active agent or an inert substance.

Control Type	Description	Purpose & Characteristics
Placebo-Controlled	The control group receives an inert material, no intervention, or a sham surgery.	Accounts for the placebo response, ensuring the observed effect is a true treatment effect rather than a psychological response.
Active-Controlled	The control group receives an active drug, which is usually the current standard of care.	Prevents the ethical problems of using a placebo when an effective standard treatment already exists.

RCTs can be structured in several ways depending on the clinical question, condition stability, and required sample size.

Trial Design	Description	Advantages & Disadvantages
Parallel Design	Patients are randomized to one of two (or more) treatment arms and each patient receives only one type of treatment.	The most common design; simple to analyze but requires a larger sample size.
Crossover Design	Patients receive both treatments in sequence (e.g., Treatment A then B, or B then A) separated by a washout period.	Patients serve as their own controls, requiring fewer participants. Limited to chronic, stable conditions. Risk of "carryover effects" from the first treatment.
Factorial Design	Tests the effect of more than one treatment simultaneously (e.g., 2x2 design).	Allows the assessment of potential interactions among the different treatments using a smaller overall sample size.
Cluster Randomized Trials	Entire groups or clusters (e.g., families, schools, hospitals) are randomized rather than individuals.	Avoids treatment contamination and is administratively convenient, but requires complex statistical analysis to account for clustering.

Blinding (Masking): Double-blind trials, where neither the patient nor the evaluating doctor knows the treatment allocation, are the gold standard to prevent the false exaggeration of treatment effects. In a single-blind trial, only one party is unaware, while in an open-label trial, both the patient and physician know the allocations.
Intention-to-Treat (ITT) Analysis: Analyzes all patients in their originally randomized group regardless of whether they completed the treatment, withdrew, or crossed over. ITT is the gold standard because it preserves the benefits of randomization and avoids attritional bias.
Per-Protocol Analysis: Analyzes only the outcomes of those participants who strictly adhered to the original intended allocated intervention. This can introduce confounding bias as it breaks the original randomization.